$59.7 Million is the total value of Rosenbaum Jay D.'s 62 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 28.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AMZN | Buy | Amazon.com Inc | $2,801,471 | -1.7% | 22,038 | +0.8% | 4.69% | +2.6% |
TMO | Buy | Thermo Fisher Scientific Inc | $1,533,189 | -2.5% | 3,029 | +0.5% | 2.57% | +1.8% |
VMW | New | VMware Inc | $1,179,511 | – | 7,085 | +100.0% | 1.98% | – |
PANW | Buy | Palo Alto Networks Inc | $1,126,953 | -4.7% | 4,807 | +3.9% | 1.89% | -0.5% |
GD | Buy | General Dynamics Corp | $1,120,760 | +25.0% | 5,072 | +21.7% | 1.88% | +30.4% |
DHR | Buy | Danaher Corp | $1,074,769 | +13.3% | 4,332 | +9.6% | 1.80% | +18.3% |
JNJ | Buy | Johnson & Johnson | $1,064,084 | +222.7% | 6,832 | +243.0% | 1.78% | +237.1% |
ICE | Buy | Intercontinental Exchange Inc | $1,034,628 | +1.3% | 9,404 | +4.1% | 1.73% | +5.7% |
DE | Buy | Deere & Co | $1,007,227 | +12.0% | 2,669 | +20.3% | 1.69% | +16.9% |
New | Linde PLC | $994,175 | – | 2,670 | +100.0% | 1.67% | – | |
NEE | Buy | NextEra Energy Inc | $976,279 | +16.4% | 17,041 | +50.8% | 1.64% | +21.5% |
LOW | Buy | Lowe's Cos Inc | $937,566 | -4.5% | 4,511 | +3.7% | 1.57% | -0.4% |
XOM | Buy | Exxon Mobil Corp | $918,182 | +11.3% | 7,809 | +1.5% | 1.54% | +16.2% |
IQV | New | IQVIA Holdings Inc | $904,066 | – | 4,595 | +100.0% | 1.52% | – |
NVS | Buy | Novartis AG Sponsored ADR | $871,412 | +4.6% | 8,555 | +3.6% | 1.46% | +9.2% |
CVX | Buy | Chevron Corp | $870,079 | +8.6% | 5,160 | +1.4% | 1.46% | +13.4% |
KO | Buy | Coca-Cola Co | $854,535 | -4.0% | 15,265 | +3.3% | 1.43% | +0.2% |
AMT | Buy | American Tower Corp | $827,019 | -13.1% | 5,029 | +2.5% | 1.39% | -9.3% |
SPY | Buy | SPDR S&P 500 ETF | $741,250 | +9.7% | 1,734 | +13.8% | 1.24% | +14.5% |
NKE | Buy | Nike Inc Cl B | $599,824 | -11.9% | 6,273 | +1.7% | 1.00% | -8.1% |
BLK | Buy | Blackrock Inc | $587,013 | -1.9% | 908 | +4.8% | 0.98% | +2.4% |
V | Buy | Visa Inc Cl A | $470,370 | +11.3% | 2,045 | +15.0% | 0.79% | +16.2% |
VUG | Buy | Vanguard Growth ETF | $435,696 | +26.8% | 1,600 | +31.8% | 0.73% | +32.2% |
UNH | Buy | UnitedHealth Group Inc | $414,948 | +51.7% | 823 | +44.6% | 0.70% | +58.3% |
VO | Buy | Vanguard Mid-Cap Index Fund ETF | $366,711 | +23.1% | 1,761 | +30.2% | 0.61% | +28.5% |
IEFA | Buy | iShares Core MSCI EAFE ETF | $362,226 | +29.8% | 5,629 | +36.2% | 0.61% | +35.5% |
VTV | Buy | Vanguard Value ETF | $330,066 | +28.6% | 2,393 | +32.5% | 0.55% | +34.2% |
VWO | New | Vanguard FTSE Emerging Markets ETF | $233,221 | – | 5,948 | +100.0% | 0.39% | – |
SPGI | Buy | S&P Global Inc | $232,035 | +3.9% | 635 | +14.0% | 0.39% | +8.4% |
LLY | New | Lilly Eli & Co | $230,429 | – | 429 | +100.0% | 0.39% | – |
VB | New | Vanguard Small-Cap Index Fund ETF | $228,207 | – | 1,207 | +100.0% | 0.38% | – |
HQY | New | HealthEquity Inc | $219,150 | – | 3,000 | +100.0% | 0.37% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-10-23
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Microsoft Corporation | 36 | Q3 2023 | 10.7% |
APPLE INC COM | 36 | Q3 2023 | 8.4% |
PROCTER & GAMBLE CO COM | 36 | Q3 2023 | 5.4% |
STRYKER CORP COM | 36 | Q3 2023 | 4.3% |
JPMORGAN CHASE & CO COM | 36 | Q3 2023 | 3.9% |
TJX COMPANIES INC COM | 36 | Q3 2023 | 3.5% |
PEPSICO INC COM | 36 | Q3 2023 | 3.1% |
US BANCORP COM | 36 | Q3 2023 | 2.6% |
INTEL CORP COM | 35 | Q2 2023 | 7.3% |
MEDTRONIC PLC | 35 | Q3 2023 | 3.3% |
View Rosenbaum Jay D.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-09 |
13F-HR | 2023-10-23 |
13F-HR | 2023-07-27 |
13F-HR | 2023-05-11 |
13F-HR | 2023-02-09 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-11 |
13F-HR | 2022-05-12 |
13F-HR | 2022-02-09 |
13F-HR | 2021-10-26 |
View Rosenbaum Jay D.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.